SK Biopharmaceuticals has launched SK Life Science LinX, an innovation space in New Jersey aimed at helping Korean biotech and pharmaceutical companies expand into the U.S. and global markets. The facility, covering about 530 square meters, will facilitate collaborations by providing legal and patent consultations, connecting businesses with local investors, and hosting academic events. The launch was marked by a partnership agreement with the Korea Trade-Investment Promotion Agency and the Korean American Society in Biotech and Pharmaceuticals, emphasizing SK Biopharmaceuticals’ commitment to fostering growth for Korean firms on the international stage.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.koreaherald.com/article/10766168
